Alberta Investment Management Corp (AIMCo)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-78,500	Closed	-$4.25M	–	750
2025 Q3	$4.25M	Buy	78,500 +5,300	+7%	+$303K	0.03%	311
2025 Q2	$4.02M	Buy	+73,200	New	+$4.31M	0.03%	300
2025 Q1	–	Sell	-58,400	Closed	-$3.84M	–	766
2024 Q4	$3.84M	Buy	+58,400	New	+$3.91M	0.03%	331
2024 Q3	–	Sell	-13,100	Closed	-$1.08M	–	772
2024 Q2	$1.08M	Buy	13,100 +9,400	+254%	+$783K	0.01%	507
2024 Q1	$323K	Hold	3,700	–	–	﹤0.01%	900
2023 Q4	$357K	Hold	3,700	–	–	﹤0.01%	882
2023 Q3	$327K	Sell	3,700 -1,871	-34%	-$166K	﹤0.01%	901
2023 Q2	$483K	Buy	5,571 +1,871	+51%	+$176K	﹤0.01%	954
2023 Q1	$360K	Sell	3,700 -46,030	-93%	-$4.77M	﹤0.01%	1043
2022 Q4	$5.15M	Sell	49,730 -2,300	-4%	-$216K	0.05%	413
2022 Q3	$4.41M	Sell	52,030 -30,000	-37%	-$2.67M	0.03%	509
2022 Q2	$6.8M	Buy	82,030 +30,230	+58%	+$2.41M	0.05%	408
2022 Q1	$3.99M	Buy	51,800 +41,200	+389%	+$3.45M	0.02%	600
2021 Q4	$937K	Hold	10,600	–	–	0.01%	778
2021 Q3	$819K	Hold	10,600	–	–	0.01%	816
2021 Q2	$884K	Buy	+10,600	New	+$840K	0.01%	797
2019 Q4	–	Sell	-56,000	Closed	-$3.77M	–	929
2019 Q3	$3.77M	Hold	56,000	–	–	0.04%	393
2019 Q2	$4.8M	Hold	56,000	–	–	0.04%	348
2019 Q1	$4.97M	Hold	56,000	–	–	0.05%	319
2018 Q4	$4.77M	Sell	56,000 -18,000	-24%	-$1.71M	0.05%	281
2018 Q3	$7.18M	Sell	74,000 -32,000	-30%	-$3.19M	0.06%	291
2018 Q2	$9.98M	Hold	106,000	–	–	0.09%	223
2018 Q1	$8.59M	Hold	106,000	–	–	0.08%	247
2017 Q4	$9.45M	Hold	106,000	–	–	0.08%	231
2017 Q3	$9.87M	Hold	106,000	–	–	0.09%	224
2017 Q2	$9.63M	Sell	106,000 -47,000	-31%	-$4.28M	0.09%	225
2017 Q1	$13.4M	Sell	153,000 -24,000	-14%	-$2.14M	0.12%	177
2016 Q4	$14.7M	Hold	177,000	–	–	0.13%	158
2016 Q3	$16.4M	Hold	177,000	–	–	0.16%	147
2016 Q2	$13.8M	Hold	177,000	–	–	0.16%	141
2016 Q1	$14.6M	Sell	177,000 -43,000	-20%	-$3.5M	0.19%	112
2015 Q4	$23M	Sell	220,000 -6,000	-3%	-$627K	0.27%	80
2015 Q3	$23.8M	Hold	226,000	–	–	0.28%	78
2015 Q2	$30.9M	Sell	226,000 -20,000	-8%	-$2.48M	0.33%	66
2015 Q1	$30.7M	Hold	246,000	–	–	0.32%	66
2014 Q4	$22.2M	Hold	246,000	–	–	0.24%	103
2014 Q3	$17.8M	Hold	246,000	–	–	0.19%	153
2014 Q2	$15.3M	Sell	246,000 -11,100	-4%	-$671K	0.17%	183
2014 Q1	$17.5M	Sell	257,100 -60,900	-19%	-$4.49M	0.21%	143
2013 Q4	$22.3M	Hold	318,000	–	–	0.28%	85
2013 Q3	$23M	Buy	+318,000	New	+$21.1M	0.3%	69

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s BMRN Position: Q4 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 78,500 shares — an estimated $4.25M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BMRN in Q3 2013 and held it in 41 quarters. The position peaked at $30.9M in Q2 2015. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

Alberta Investment Management Corp (AIMCo) reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 78,500 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $4.25M.
Alberta Investment Management Corp (AIMCo) first reported a position in BioMarin Pharmaceuticals in Q3 2013 and held it in 41 quarters.
Alberta Investment Management Corp (AIMCo)'s BioMarin Pharmaceuticals position peaked at $30.9M in Q2 2015.
539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2025, filed 17 Feb 2026.